Skip to main content
FinSpry Logo
FinSpry
KLRS logo
KLRS
(NASDAQ)
Kalaris Therapeutics, Inc.
$5.79-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Kalaris Therapeutics (KLRS) Stock Price & Financial Analysis

Kalaris Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.53 - $6.10
52-Week High$11.88
52-Week Low$2.14
Open$5.75
Volume23.57K
Average Volume (3M)23.57K
Market Cap108.28M
Shares Outstanding18.70M
Price to Book (P/B)2.65
EV/EBITDA-1.01
50-Day MA$8.80
200-Day MA$5.97
52-Week Change-25.81%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Kalaris Therapeutics

What is the current stock price for KLRS?

As of the latest trading session, KLRS stock trades at $5.79. The 52-week range is $2.14–$11.88, with a day range of $5.53–$6.09.

What is the P/E ratio for KLRS?

The P/E ratio (Price-to-Earnings) for KLRS is shown in the Key Statistics section. This valuation metric helps compare Kalaris Therapeutics, Inc. to industry peers.

Does KLRS pay dividends?

Kalaris Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KLRS?

Analyst ratings and recommendations for KLRS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of KLRS?

Kalaris Therapeutics's market capitalization is $108.3M, classifying it as a micro-cap company. Kalaris Therapeutics operates in the Healthcare sector within the Biotechnology industry.